Recently, new possibilities for the use of CB1954 have cal changes in murine L cells, including the generation of enlarged, multinucleate cells. The authors proposed that arisen with the advent of antibody-directed enzyme prodrug therapy (ADEPT) 2 and gene-directed enzyme prothese changes could be explained by a block in DNA synthesis with continued RNA and protein synthesis. We too drug therapy (GDEPT).
3 In these approaches either E. coli nitroreductase (NTR) which can also catalyse CB1954 have observed similar morphological changes in V79 Chinese hamster cells (Bailey et al, unpublished data) and reduction, 2 or the gene encoding this enzyme are delivered to the tumour site where they locally activate profound that cytotoxic doses of CB1954 result in a block in the G2/M phase of the cell cycle. DNA strand breaks and drug. Two articles in this issue of Gene Therapy show the potential of the latter approach. 4, 5 interstrand cross-links were observed in CB1954-treated cells, 4 suggesting that these may be involved in the mechBoth groups have limited expression of the bacterial enzyme to specific cellular targets by placing the gene anism of cytotoxicity. Possibly as a consequence of these lesions in the genome the cells appear to undergo apopunder the transcriptional control of tissue-specific elements. In the work of Clark et al 4 the ovine ␤-lactoglotosis. Thus Drabek and co-workers, 5 who targeted NTR expression to T cells using the CD2 locus control region bulin promoter limited expression to the luminal cells of the mammary gland whereas in Drabek et al's studies 5 (LCR), reported an increased proportion of apoptotic thymocytes in CB1954-treated mice relative to controls. Thycontrol elements of the human CD2 locus restricted nitroreductase expression to T cells. This targeted destruction mocytes readily undergo apoptosis but this does not appear to be an idiosyncratic lineage-specific response of particular cell types allowing the ablation of selected tissues offers a powerful tool for many types of studies.
since Clark et al 4 also observed high apoptotic levels in targeted mammary luminal cells. Whether this cell Though, as both groups point out, it is the possibility of using the nitroreductase (NTR) gene in anticancer therresponse to CB1954-induced damage is a universal phenomenon remains to be determined. What is clear is apy which appears to offer greatest promise. However, while transgenics provide a model for studying the in that CB1954, when activated by NTR, exerts the bystander phenomenon in vitro. This characteristic, vivo efficacy of NTR/prodrug therapy, they may not be particularly predictive of the clinical situation where levthought to be such an important component of potential prodrugs utilisable for 'suicide gene therapy', has been els of gene transfer are unlikely to be as high.
None the less, in several human and murine cell lines, documented in tissue culture experiments. 7 Whether such a phenomenon always occurs in targeted tissues in transfollowing either plasmid or retroviral gene delivery, [4] [5] [6] [7] the differential toxicity to CB1954 between cells expressgenic mice, and whether it has any effect upon tissuespecific ablation, remains rather uncertain at this point. ing the NTR gene and nonexpressing control cells has reached 10-100-fold and therefore is as impressive as that Thus Drabek and colleagues suggest that the killing of nonexpressing B cells was a consequence of an in vivo observed with other 'suicide genes' like the HSVtk.
CB1954 appears to act more rapidly than some other bystander response 5 while in Clark's studies mammary luminal cells were ablated completely leaving closely suicide gene prodrugs such as ganciclovir, and in vitro effects have been noted when as little as 4-h drug associated myoepithelial cells unaffected. Lambeth Palace Road might be to minimise the bystander effect whereas in London SE1 7EH, UK tumour destruction the aim would be to maximise the response. In this regard, perhaps it is disappointing that References in cell culture experiments with 5-10% of murine L cells expressing NTR, a figure which might be at the upper
